Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc. (SNDX) — Form 8-K: Current report
About this filing
Syndax Pharmaceuticals, Inc. (SNDX) filed an 8-K on Nov 2, 2026 reporting results of operations (earnings) (Item 2.02) and an executive or director change or pay arrangement (Item 5.02), with exhibits (Item 9.01).
Key facts
- Item 2.02 · Results of operations (earnings)
- Item 5.02 · Executive or director change or pay arrangement
- Item 9.01 · Financial statements and exhibits
More SNDX filings
- 4
Filed Nov 12, 2026
- 3
Filed Nov 12, 2026
- 10-Q
Filed Nov 2, 2026
- 4
Filed Oct 30, 2026
- 144
Filed Oct 29, 2026
- SC 13G
Filed Aug 7, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.